Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate

被引:0
作者
van Drunen, C
Meltzer, EO
Bachert, C
Bousquet, J
Fokkens, WJ
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DD Amsterdam, Netherlands
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Ghent Univ Hosp, ENT Dept, B-9000 Ghent, Belgium
[4] Cent Hosp Univ, Hop Arnaud de Villeneuve, Dept Resp Dis, Montpellier, France
关键词
mometasone furoate; allergic rhinitis; nasal allergies; intranasal corticosteroids;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mometasone furoate nasal spray (MFNS; Nasonex(R), Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.
引用
收藏
页码:5 / 19
页数:15
相关论文
共 50 条
  • [31] Clinical effectiveness of fluticasone furoate nasal spray for perennial allergic rhinitis in children: a comprehensive review
    Rivera, Paola Andrea
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [32] Efficacy and safety of mometasone furoate 0.1% once daily versus fluticasone propionate 0.005% twice daily in the management of psoriasis
    De Villez, RL
    Sher, AM
    Breneman, DL
    Espy, PD
    Garcia, CJ
    Monroe, EW
    Tanner, DJ
    Cuffie, CA
    ADVANCES IN THERAPY, 1998, 15 (02) : 92 - 97
  • [33] Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids
    D'Urzo, A
    Karpel, JP
    Busse, WW
    Boulet, LP
    Monahan, ME
    Lutsky, B
    Staudinger, H
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1281 - 1289
  • [34] A comparison of the efficacy and safety of the combination mometasone furoate 0.1% salicylic acid 5% ointment with each of its components in psoriasis
    Katz, HI
    Tanner, DJ
    Cuffie, CA
    Brody, NI
    Garcia, CJ
    Lowe, NJ
    Medansky, RS
    Roth, HL
    Shavin, JS
    Swinyer, LJ
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1998, 9 (03) : 151 - 156
  • [35] Efficacy and safety of fluticasone furoate nasal spray in adult and adolescent subjects with uncomplicated acute rhinosinusitis
    Paul Keith
    Andrzej Dymek
    Oliver Pfaar
    Wytske Fokkens
    Nazli Topors
    Wei Wu
    Suyong Yun Kirby
    Laurie A Lee
    Allergy, Asthma & Clinical Immunology, 7 (Suppl 2)
  • [36] Clinical efficacy and safety of local nasal immunotherapy
    Andri, L
    Senna, GE
    Dama, AR
    ALLERGY, 1997, 52 : 36 - 39
  • [38] Comparative efficacy of intranasal mometasone furoate monotherapy or combination therapy with montelukast in pediatric adenoid hypertrophy: A systematic review and meta-analysis of randomized clinical trials
    Almutairi, Rahaf H.
    Albesher, Meshal Bassam
    Alboqami, Razan Ayed
    Al-Fahd, Abdullah Zaki
    Alshehri, Rayan Fahad Z.
    Ateeq, Orjwan Hashem
    Halawani, Mohammed
    Alshammari, Jaber
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2025, 192
  • [39] An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis
    Faergemann, J
    Christensen, O
    Sjövall, P
    Johnsson, A
    Hersle, K
    Nordin, P
    Edmar, B
    Svensson, A
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2000, 14 (05) : 393 - 396
  • [40] Comparative Efficacy of Mometasone Nasal Spray Combined with Different Doses of Desloratadine, and Montelukast in Childhood Allergic Rhinitis: A Randomized Clinical Trial
    Ghanbari, Niloufar
    Eftekhari, Kambiz
    Samadzadeh-Mamaghani, Mohammadreza
    Sedighiyan, Mohsen
    Diaz, Diana Noemi
    Shafiei, Alireza
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2024, 23 (04) : 366 - 373